Navigation Links
Activity Against Key Drug-Resistant Pathogens is the Most Important Attribute Influencing Surveyed Physicians' Antibiotic Selection for Nosocomial Pneumonia in the U.S.
Date:11/2/2010

MALVERN, Pa., Nov. 2, 2010 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that the leading driver of antibiotic selection in nosocomial pneumonia in the United States is activity against key drug-resistant pathogens. Such pathogens include P. aeruginosa, MRSA, Vancomycin-resistant Staphylococcus aureus and multidrug-resistant Steptococcus pneumonia.

"Nosocomial pneumonia is one of the most important indications for hospital antibiotics in the U.S. because of its relatively high morbidity and mortality and high frequency of drug-resistant pathogens," stated James Andersen, analyst at AMR.

In the new report entitled Hospital Anti-Infectives Insight Series: Nosocomial Pneumonia, surveyed physicians indicate that the excellent bactericidal activity and lung penetration of Pfizer's Zosyn are primary reasons for its success in the nosocomial pneumonia drug market, while Pfizer's success with Zyvox is largely driven by its convenient availability in a dual IV/oral formulation. Johnson & Johnson's success with Levaquin is driven by a high level of experience among surveyed physicians, relatively high activity against nosocomial pneumonia pathogens, low dosing frequency and dual IV/oral formulation.

About the Report

AMR's Hospital Anti-Infectives Insight Series: Nosocomial Pneumonia analyzes hospital antibiotic prescribing patterns using AMR's comprehensive and highly detailed clinical data in conjunction with primary research and extensive understanding of emerging therapies and forecasts. This report contains U.S. data and examines the reasons behind physicians' product preferences, factors driving hospital antibiotic prescribing patterns and receptivity to emerging antibiotics.

About AMR

AMR (www.AMR-data.com) serv
'/>"/>

SOURCE Arlington Medical Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
3. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
4. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
5. Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
6. Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors
7. Updated Phase 1 Data for Exelixis XL184 Demonstrate Pharmacodynamic and Clinical Anti-Tumor Activity
8. Kosan Presents Phase 1 Data Showing Antitumor Activity and Safety Profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting
9. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
10. Human Genome Sciences Presents New Data Showing Anti-Tumor Activity And Safety Of Trail Receptor Antibodies In Combination With Chemotherapy
11. BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... CAMBRIDGE, Mass. , Sept. 19, 2014   ... of advanced cancer genome analysis and testing services, ... discovering and developing highly selective kinase inhibitors for ... genomic study of malignant mixed Mullerian tumors (MMMT), ... reproductive system, also known as carcinosarcoma. The new ...
(Date:9/19/2014)... -- PCI is pleased to announce it has acquired ... provider of Clinical Trial Services and Temperature Controlled ... in the United Kingdom ... in the UK/EU to support global investigational studies ... distribution capacity, as well as consultative services for ...
(Date:9/18/2014)... , Sept. 18, 2014  Low T ... committee meeting in Hyattsville, Maryland ... to assess the proper patient population for testosterone ... cardiovascular risk associated with TRT. Examining recent claims from ... found that "available epidemiological studies do not provide ...
Breaking Medicine Technology:First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2
... Mich., April 28, 2011 Perrigo Company (Nasdaq: ... declared a quarterly dividend of $0.07 per share, ... record on May 27, 2011. Perrigo ... develops, manufactures and distributes over-the-counter (OTC) and generic ...
... 2011 Q1 2011 Change on a reported basis ... A/H1N1 salesNet sales , euro 7,779m-1.5% , -5.2% ... -16.1% , -5.8%Business EPS(1)euro 1.66-10.8%-16.1%-6.0% In order to facilitate ... our business net income statement. Business net income(1) is ...
Cached Medicine Technology:sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 2sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 3sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 4sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 5sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 6sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 7sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 8sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 9sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 10sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 11sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 12sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 13sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 14sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 15sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 16sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 17sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 18sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 19sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 20sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 21sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 22sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 23sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 24sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 25sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 26sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 27sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 28sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 29sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 30sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 31sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 32
(Date:9/21/2014)... (PRWEB) September 21, 2014 Faculty and staff ... a coed preschool in Owings Mills, Md., kicked off the ... Garmin Vivofit bands. GFS is the first independent school to ... calories burned and even sleep patterns— as part of a ... area running and walking specialty chain. The Vivofit bands are ...
(Date:9/20/2014)... Recently, iFitDress.com, a well-known wedding dress manufacturer and ... dresses . In addition, the company has launched a special ... promotion is to benefit all of its big fans. Worldwide ... now. , Along with beautiful party dresses, the company ... recently released its new sexy short prom outfits and purple ...
(Date:9/20/2014)... Las Vegas, NV (PRWEB) September 21, 2014 ... and method created by fitness expert Craig Ballantyne that is ... boost their metabolism and blast away stubborn body fat using ... the attention of Shane Michaels, prompting an investigative review. ... equation isn’t always calories in vs. calories out for all ...
(Date:9/20/2014)... Increases in household, construction and commercial ... volumes. However, government regulations and higher landfill disposal ... to IBISWorld industry analyst Alen Allday, “over the ... reducing the volume of waste generated, and increasing ... a large proportion of waste generated by households ...
(Date:9/20/2014)... York, New York (PRWEB) September 20, 2014 ... filings continue to grow in federal court, Bernstein ... Food & Drug Administration (FDA) have voted overwhelmingly ... low testosterone in men be subjected to further ... According to a report published on September 18th ...
Breaking Medicine News(10 mins):Health News:Garrison Forest School Leader in Independent School Wellness Programs 2Health News:Beautiful Party Dresses For Autumn Unveiled By iFitDress.com 2Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3
... doubled their odds of success , , FRIDAY, ... can improve the chances that blacks who have kidney ... found. , "Research overwhelmingly indicates that African-Americans are less ... differences in socioeconomic and insurance status and patient preference," ...
... in New Financing- DailyMed(TM) Sales Expected to Increase More ... Resources, Inc. (NYSE Amex: KAD ), a ... the Arcadia HealthCare(SM) brand, today announced that it has ... outstanding debt, extending the maturity to April 2012, and ...
... March 27 Emageon Inc. (Nasdaq: EMAG ), ... networks, today announced that it and the other named defendants ... March 13, 2009 in connection with the proposed acquisition of ... entered into a memorandum of understanding with counsel for the ...
... of a single-engine turboprop plane in Montana killed 14 people ... crashes in recent months, including the February 12th crash of ... "Miracle on the Hudson" in which all 155 people survived, ... The horror of such an event is unimaginable, but author ...
... an estimated 1.5 million people in 2007. By 2013, the ... as many as 4 million Americans and that the cost ... $400 billion, making it the nation,s fastest-growing developmental disability. In ... the DePaul University College of Law will explore ...
... Illinois Medical District Commission , ... Chicago, IL (PRWEB) ... (IMD), the nation,s largest urban healthcare, educational, research and technology district, ... its Commission. Harte comes to the IMD with a strong background ...
Cached Medicine News:Health News:Networking May Aid Blacks Who Need Kidney Transplant 2Health News:Arcadia Completes New Financing; Previews Fourth Quarter Results 2Health News:Arcadia Completes New Financing; Previews Fourth Quarter Results 3Health News:Arcadia Completes New Financing; Previews Fourth Quarter Results 4Health News:Arcadia Completes New Financing; Previews Fourth Quarter Results 5Health News:Arcadia Completes New Financing; Previews Fourth Quarter Results 6Health News:Arcadia Completes New Financing; Previews Fourth Quarter Results 7Health News:Emageon Settles Shareholder Class Action Lawsuit 2Health News:Emageon Settles Shareholder Class Action Lawsuit 3Health News:Emageon Settles Shareholder Class Action Lawsuit 4Health News:What Is It Like to Survive a Plane Crash? A Survivor of One of the Worst Small Plane Crashes Tells Her Story 2Health News:Health Law Institute at DePaul University College of Law to Host Autism Symposium on World Autism Day, April 2 2Health News:Meghan Harte Appointed to the Illinois Medical District Commission 2
... The AngioJet Xpeedior+120 Rheolytic Thrombectomy catheter is ... performance. Powerful saline jets create a low ... a vacuum effect. Thrombus is drawn into ... the jets, and removed from the body.,AngioJet ...
... CARTO XP Electroanatomical Mapping System combines the ... the operating ease of Windows* software. ... adding powerful new tools that enhance your ... takes you into the future of EP. ...
... generators are meeting the clinical needs ... and anesthesiologists. And, they are of ... from Medtronic.,Effective pacing with the adjustment ... for quick battery changes. Both ...
... Medtronic's temporary pulse generators are ... surgeons, nurses, cardiologists, electrophysiologists and anesthesiologists. ... and durability you expect from Medtronic.,Effective ... Reverse battery polarity for quick ...
Medicine Products: